regadenoson has been researched along with Coronary Vasospasm in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Fahed, AC; Grewal, S; Osborne, MT; Qamar, I; Tawakol, A; Weiner, R | 1 |
Auerbach, A; Jauhar, R; Lee, A; Makaryus, JN; Platsman, Z | 1 |
Bagley, SJ; Lilly, SM; Litwack, AJ | 1 |
3 other study(ies) available for regadenoson and Coronary Vasospasm
Article | Year |
---|---|
PET myocardial perfusion imaging of regadenoson-induced coronary vasospasm.
Topics: Coronary Artery Disease; Coronary Vasospasm; Humans; Myocardial Perfusion Imaging; Purines; Tomography, Emission-Computed, Single-Photon | 2023 |
Regadenoson-induced coronary vasospasm resulting in severe reversible perfusion defects and transient ischemic dilation on SPECT stress myocardial perfusion imaging.
Topics: Coronary Circulation; Coronary Vasospasm; Dilatation; Humans; Myocardial Perfusion Imaging; Purines; Pyrazoles; Tomography, Emission-Computed, Single-Photon | 2016 |
Coronary vasospasm during a regadenoson stress test.
Topics: Adenosine A2 Receptor Agonists; Adult; Coronary Circulation; Coronary Vasospasm; Electrocardiography; Heart Function Tests; Humans; Male; Myocardial Perfusion Imaging; Purines; Pyrazoles | 2012 |